Biosimilar Newsletter Archive

  1. 01.16.25 -- Become A cGMP "Special Agent" With A License To Care 1/16/2025
    01/16/25 Biosimilar Development Newsletter
  2. 01.09.25 -- AP Biosciences' Approach To Complex Antibody Manufacturing 1/9/2025
    01/09/25 Biosimilar Development Newsletter
  3. 01.02.25 -- Cell Culture Trends To Watch In 2025 1/2/2025
    01/02/25 Biosimilar Development Newsletter
  4. 12.19.24 -- How To Ensure 21 CFR Part 11 Compliance 12/19/2024

    12/19/24 Biosimilar Development Newsletter

  5. 12.19.24 -- 4 Technologies To Transform The Supply Chain in 2025 12/19/2024
    12/19/24 Biosimilar Development Newsletter
  6. 12.15.24 -- Is The BIOSECURE Act The First Real Step Toward Reshoring? 12/15/2024
    12/15/24 Biosimilar Development Newsletter
  7. 12.13.24 -- All Eyes On Sustainability 12/13/2024

    12/13/24 Biosimilar Development Newsletter

  8. 12.12.24 -- Is The BIOSECURE Act The First Real Step Toward Reshoring? 12/12/2024
    12/12/24 Biosimilar Development Newsletter
  9. 12.05.24 -- Filter Integrity Testing Annex 1 Requirements For Biologics DS 12/5/2024
    12/05/24 Biosimilar Development Newsletter
  10. 11.27.24 -- A Comprehensive Guide For Supplier Quality Agreements 11/27/2024
    11/27/24 Biosimilar Development Newsletter